Hematologic Flashcards
What does an endothelial cell normally secrete to repel circulating thrombocytes? (Two things)
- Prostocyclin (PG12)
2. Nitrous oxide (NO)
This proteolytic enzyme converts fibrinogen to fibrin:
Thrombin
What are the three phases of clotting?
- Platelet Adhesion
- Platelet Activation
- Platelet Aggregation
How do NO and PGI2 affect platelets?
They induce cAMP synthesis, which decreases intracellular Ca++ and INHIBITS GPIIb/IIIa activation
Damaged endothelial cells expose what?
Von Willebrand factor (vWF) and collagen
Name the top three chemical mediators secreted by adhered/activated platelets:
- ADP (Adenosine diphosphate)
- TXA2 (thromboxane A2)
- 5HT (Serotonin)
What action does local 5HT released by activated platelets have in the area of the endothelial damage?
Vessel spasm, reducing blood loss
Primary actions of TXA2?
- Stimulate activation and aggregation of platelets
2. Potent vasoconstrictor
What is thrombin’s job?
To convert fibrinogen to fibrin
What is the function of the GPIIb/IIIa receptors on thrombocytes?
Facilitate platelet-platelet interaction; fibrin bridge connects the GPIIb/IIIA receptors of one platelet to another
This pathway is shorter, and measured by PT/INR:
Extrinsic pathway
This pathway in longer, and measured by aPTT:
Intrinsic pathway
Which pathway is vitamin K dependent? Extrinsic or intrinsic?
Extrinsic, because it starts with Factor VII (which is Vitamin K dependent)
Name three natural anticoagulants:
- Protein C
- Protein S
- Anti-thrombin III
Which pathway is prothrombin time (PT) used to monitor?
Which factor is involved?
What does that factor need in order to be synthesized?
Extrinsic pathway
Factor VII
Vitamin-K dependent
Which factors are Vitamin K-dependent?
Which has the shortest life-span?
Which has the longest?
Factors II, VII, IX, X
Shortest: VII
Longest: II (thrombin)
Which pathway does the aPTT test assess?
The intrinsic pathway
What are the elements of Virchow’s Triad?
- Vascular wall injury
- Stasis
- Hypercoagulable state
MOA for ASA?
IRREVERSIBLY inhibits COX-1 and 2
Stops conversion of AA to prostaglandin, leading to less TXA2
Leads to inhibition of platelet aggregation, decreased inflammation
ASA dose range for prevention of cardiovascular events:
50mg to 160mg
Top risk of ASA use:
GI bleeding
Rare SE of ASA?
Reye’s Syndrome - swelling of the liver and brain (peds)
Avoid use of salicylates in children
ASA pregnancy category?
C/D —> avoid in 3rd trimester
*APAP —> preferred for pregnancy
Dipyrimadole MOA?
- Stimulates PGI2 synthesis
- Stimulates cAMP
- Inhibits platelet aggregation
Dipyrimadole use?
- Combined with ASA to prevent CVA (ischemic)
2. Post-heart valve replacement thrombus prevention
Dipyrimadole SE’s?
Coronary steal phenomenon: unstable angina patients
Caution when used with anticoagulants
Aggrenox (ASA and Dipyridamole) - use?
Reduce risk of stroke in pt’s who have already experienced TIA or CVA
Aggrenox - CI’s?
Reye’s Syndrome
Cilostazol - MOA?
PDE3 inhibitor
Inhibits cAMP breakdown
Inhibits platelet aggregation
Vasodilatory in vascular smooth muscle
Cilostazol - use?
Intermittent claudication (muscle pain) symptom relief
Cilostazol - SE’s?
Cardiac (palpitation, tachyarryhthmias)
HA
Diarrhea
Cilostazol - CI’s?
BLACK BOX: HF
Vorapaxar - MOA?
PAR-1 antagonist
Inhibits thrombin-induced platelet aggregation
Does NOT inhibit platelet aggregation via ADP, vWF, etc
Vorapaxar - use?
Prevention of thrombotic events in pt’s with hx of MI or PAD
Vorapaxar - CI’s?
Not for use in ACS
Avoid use with strong CYP3A inhibitors or inducers
Avoid use with anticoagulants
Clopidogrel (Plavix) and Prasugrel (Effient) - MOA?
IRREVERSIBLY inhibits ADP from binding to P2Y12 receptor - leads to inhibition of GPIIb/IIIa expression (required for platelet aggregation)
Ticagrelor - MOA?
REVERSIBLY inhibits ADP from binding to P2Y12 receptor - leads to inhibition of GPIIb/IIIa expression (required for platelet aggregation)
Clopidogrel/Prasugrel - use?
Prevention of atherosclerotic events for pt’s with:
Recent stroke or MI, or PAD
Post-PCI patients
Ticagrelor - use?
ACS patients
Clopidogrel - active or prodrug?
Prodrug
Prasugrel- active or prodrug?
Prodrug
Ticagrelor - active or prodrug?
Active
Cangrelor - MOA?
Inhibits binding of ADP to P2Y12 receptor
Cangrelor - use?
Adjunct to PCI
Abciximab - MOA?
Monoclonal antibody GPIIb/IIIa receptor inhibitor
Abciximab - use?
Adjunct to PCI
Ebtifibatide - MOA?
GPIIb/IIIa receptor inhibitor - prevents binding of fibrin to GPIIb/IIIa, preventing platelet aggregation
Eptifibatide - use?
ACS, PCI
Tirofiban - MOA?
GPIIb/IIIa receptor inhibitor - prevents binding of fibrin to GPIIb/IIIa, preventing platelet aggregation
Tirofiban - use?
ACS, PCI
Eptifibatide and Tirofiban - considerations?
Renal insufficiency